Skin Autofluorescence a Non-Invasive Biomarker of Advanced Glycation End-Products and Its Association to Metabolic Parameters in a Greek Diabetic Population
DOI:
https://doi.org/10.17140/DROJ-7-151Keywords:
Diabetes mellitus (DM); Advanced glycation end-products (AGEs), Skin autofluorescence (SAF); Empirical findings.Abstract
This cross-sectional study aims to evaluate the association between advanced glycation end-products (AGEs) accumulation, assessed
by skin autofluorescence (SAF) measured using the AGE Reader, and the prevalence of several metabolic variables in a diabetic
population The measurement of SAF has become a non-invasive method of assessing the accumulation of AGEs as a marker of the long-term impact of glycemic and oxidative stress in humans. In contrast to blood glucose and to hemoglobin A1C (HbA1c), which reflect a short period of glucose levels, the AGE is a marker of the metabolic legacy effect and reflect a long period of glucose levels. AGEs play a pivotal role in the development and progression of diabetic complications. SAF has been validated as a simple, non-invasive method for assessment of AGEs accumulation in the body.
References
Vlassara H. Advanced glycation in health and disease: role of the modern environment. Ann N Y Acad Sci. 2005; 1043: 452-460. doi: 10.1196/annals.1333.051
Vlassara H, Uribarri J. Glycoxidation and diabetic complica-tions: Modern lessons and a warning? Rev Endocr Metab Disord. 2004; 5: 181-188. doi: 10.1023/B:REMD.0000032406.84813.f6
Vlassara H, Striker G. AGE restriction in diabetes mellitus: A paradigm shift. Nat Rev Endocrinol. 2011; 7: 526-539. doi: 10.1038/ nrendo.2011.74 Submit your article to this journal | https://openventio.org/submit-manuscript/ 15 Folinas D et al
Vlassara H, Striker G. The role of AGE-products in the etiol-ogy of insulin resistance and diabetes. US Endocrinology. 2010; 6: 14-19. doi: 10.17925/use.2010.06.1.14
Vlassara H. AGEs as a preventable cause of diabetes and its complications. Diabetological Chronicles. 2011; 24(3): 155-160.
Schleicher E, Wagner E, Nerlich AG. Increased accumulation of the glyoxidation product N-(carboxymethyl) lysine in human tissues in diabetes and aging. J Clin Invest. 1997; 9: 457-468. doi: 10.1172/JCI119180
Meerwaldt R, Hartog JW, Graaff R, Huisman RJ, Links TP, den Hollander NC, et al. Skin autofluorescence, a measure of cumula-tive metabolic stress and advanced glycation end products, pre-dicts mortality in hemodialysis patients. J Am Soc Nephrol. 2005; 16: 3687-3693. doi: 10.1681/ASN.2005020144
de Vos LC, Noordzij MJ, Mulder DJ, Smit AJ, Lutgers HL, Dullaart RPF, et al. Skin autofluorescence as a measure of ad-vanced glycation end products deposition is elevated in peripheral artery disease. Arterioscler Thromb Vasc Biol. 2013; 33: 131-138. doi: 10.1161/ATVBAHA.112.300016
de Vos LC, Boersema J, Mulder DJ, Smit AJ, Zeebregts CJ, Le-frandt JD, et al. Skin autofluorescence as a measure of advanced glycation end products deposition predicts 5-year amputation in patients with peripheral artery disease. Arterioscler Thromb Vasc Biol. 2015; 35: 1532-1537. doi: 10.1161/ATVBAHA.115.305407
van Waateringe RP, Slagter SN, van Beek AP, van der Klauw MM, van Vliet-Ostaptchouk JV, Graaff R, et al. Skin autofuores-cence, a non-invasive biomarker for advanced glycation end prod-ucts, is associated with the metabolic syndrome and its individual components. Diabetol Metab Syndr. 2017; 9: 42. doi: 10.1186/ s13098-017-0241-1
Lutgers HL Graaff R, Links TP, Ubink-Veltmaat LJ, Bilo HJ, Gans RO, et al. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care. 2006; 29: 2654-2659. doi: 10.2337/dc05-2173 Brief Research Report | Volume 7 | Number 1 |
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Diabetes Research (DR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
